The fifth meeting of the Hepatitis B and C Network aims to bring together experts from across the EU to discuss how Europe can improve its response to the epidemics of hepatitis B and C with a focus on surveillance, estimating prevalence, and the monitoring of response.
This presentation summarises the main data from the ECDC Annual epidemiological reports 2017 on chlamydia, gonorrhoea, lymphogranuloma venereum, (congenital) syphilis
Recent epidemics of Ebola virus disease in Africa have increased the potential risk of Ebola virus transmission via donated blood and blood components, cells, tissues and organs (substances of human origin; SoHO), not only locally and regionally in Africa, but also in non-endemic unaffected areas such as Europe due to population movements.
In the EU/EEA, almost every second HIV diagnosis happened at a late stage in 2017. This means diagnosis several years after infection.
In 2007, 49 % of those with a CD4 cell count reported at HIV diagnosis were diagnosed late (several years after infection).
In a two-day meeting organised by ECDC and UNAIDS, representatives of 22 European countries discussed how to improve the delivery of HIV pre-exposure prophylaxis (PrEP) across Europe. The meeting brought together country delegates, PrEP users and community HIV advocates to seek ways to strengthen the provision and monitoring of PrEP.